Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Impact
Culture
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set actionable strategy
Build products, services, and experiences
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Safer societies
Regenerative futures
Impact
Culture

Pharma and biotech

Showing 51-60 of 81 results
Sort by:
Woman examining laboratory samples
In the media

The RNA Therapeutics Race: How can pharma stay ahead of the wave?

It is crucial for pharmaceutical companies to strategically position themselves within the RNA sector.
Advancing RNA
05 December 2023
Woman examining laboratory samples
Sharing hobbies is good for the heart!
In the media

Three steps to improve and measure your clinical trial patient diversity efforts

How can life sciences companies successfully measure the impact of diversity improvement initiatives within clinical trials.
Clinical Leader
21 November 2023
Sharing hobbies is good for the heart!
Business people brainstorming at whiteboard in office
In the media

Key considerations for Cell & Gene Therapy developers to tap into AI

A look at outsourcing vs. developing in-house solutions, data acquisition strategies, the three stages of managing AI/ML algorithms, and more.
Cell & Gene
24 October 2023
Business people brainstorming at whiteboard in office
Analytical chemistry sample being pipetted into test tube for analysis in laboratory
In the media

Opportunities for AI to assist Cell & Gene therapy companies

PA Consulting life sciences expert Yoshio Hagiwara, PA cell & gene expert Paolo Siciliano, and Willem van Asperen, PA's chief data scientist, explain how AI can transform the cell & gene sector.
Cell & Gene
10 October 2023
Analytical chemistry sample being pipetted into test tube for analysis in laboratory
Two scientists standing in a lab and going over data in a notebook
In the media

Home use and sustainability opportunities leading to a renaissance in Lyophilized drugs

PA Consulting pharma and medtech design expert Bill Hartman explains how distributing therapies in powder form can improve logistics and better enable some patients to self-administer drugs at home.
Partnership Opportunity in Drug Delivery
01 October 2023
Two scientists standing in a lab and going over data in a notebook
Close-up of machinery
In the media

EU medtech labeling compliance and the competitive advantage of a digitalized process

PA's Rowan Nidd and Maggie Chain discuss EU labeling compliance, optimization, and digitalization for medtech devices.
Med Device Online
26 September 2023
Close-up of machinery
Businessmen discussing ideas in open plan office
In the media

Why it's imperative to improve your program governance

Sierra Nesbit and Erik Moen, life sciences experts at PA Consulting, authored an article for Life Science Leader sharing three paths pharma companies can take to improve their project management outputs.
Life Science Leader
01 September 2023
Businessmen discussing ideas in open plan office
Person speaking on the phone
In the media

Four ways Academic Medical Centers can capture greater value in the Cell & Gene Therapy industry

PA Consulting cell and gene experts Gloria Lam and Paolo Siciliano share key factors for leveraging Academic Medical Centers’ unique advantages to develop and deliver cell and gene therapies.
Cell & Gene
22 August 2023
Person speaking on the phone
Healthier at home
Insight

Pharma companies: The prime mover in supporting people to be healthier at home

Pharma leaders must adapt to hospital to home care by collaborating with stakeholders, and prioritising patient needs to drive value.
Healthier at home
Through the glass view of businessman talking to colleagues in conference room meeting
In the media

Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say

PA Consulting life sciences expert Stephen Morehouse discusses the pharma and biotech M&A outlook for the second half of 2023.
MarketWatch
12 July 2023
Through the glass view of businessman talking to colleagues in conference room meeting